UBS maintains Coherus BioSciences at 'buy' with a price target of $7.00 August 7, 2023 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Piper Sandler maintains American Well at 'neutral' with a price target of $2.00 Back: All Posts Next:UBS maintains Berkshire Hathaway B at 'buy' with a price target of $414.00